🇺🇸 Xopenex in United States

FDA authorised Xopenex on 25 March 1999

Marketing authorisation

FDA — authorised 25 March 1999

  • Marketing authorisation holder: OAK PHARMS INC
  • Status: approved

Xopenex in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in United States

Frequently asked questions

Is Xopenex approved in United States?

Yes. FDA authorised it on 25 March 1999.

Who is the marketing authorisation holder for Xopenex in United States?

OAK PHARMS INC holds the US marketing authorisation.